A detailed history of Black Rock Inc. transactions in Zai Lab LTD stock. As of the latest transaction made, Black Rock Inc. holds 660,587 shares of ZLAB stock, worth $13.9 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
660,587
Previous 649,275 1.74%
Holding current value
$13.9 Million
Previous $10.4 Million 10.06%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$13.72 - $21.55 $155,200 - $243,773
11,312 Added 1.74%
660,587 $11.4 Million
Q1 2024

May 10, 2024

BUY
$15.95 - $26.8 $1.41 Million - $2.38 Million
88,626 Added 15.81%
649,275 $10.4 Million
Q4 2023

Feb 13, 2024

BUY
$22.97 - $30.58 $716,250 - $953,545
31,182 Added 5.89%
560,649 $15.3 Million
Q3 2023

Nov 13, 2023

SELL
$22.72 - $31.49 $1.42 Million - $1.96 Million
-62,373 Reduced 10.54%
529,467 $12.9 Million
Q2 2023

Aug 11, 2023

SELL
$25.3 - $39.67 $95.9 Million - $150 Million
-3,789,907 Reduced 86.49%
591,840 $16.4 Million
Q1 2023

May 12, 2023

BUY
$30.21 - $48.1 $2.43 Million - $3.86 Million
80,310 Added 1.87%
4,381,747 $146 Million
Q4 2022

Feb 13, 2023

SELL
$22.28 - $38.71 $9,981 - $17,342
-448 Reduced 0.01%
4,301,437 $132 Million
Q3 2022

Nov 14, 2022

SELL
$34.2 - $51.69 $923,023 - $1.4 Million
-26,989 Reduced 0.62%
4,301,885 $147 Million
Q2 2022

Aug 12, 2022

BUY
$23.14 - $49.68 $9.36 Million - $20.1 Million
404,659 Added 10.31%
4,328,874 $150 Million
Q1 2022

May 12, 2022

BUY
$27.77 - $64.4 $6.44 Million - $14.9 Million
231,759 Added 6.28%
3,924,215 $173 Million
Q4 2021

Feb 10, 2022

SELL
$54.9 - $105.21 $16.1 Million - $30.8 Million
-293,194 Reduced 7.36%
3,692,456 $232 Million
Q3 2021

Nov 09, 2021

BUY
$105.0 - $178.37 $8.8 Million - $14.9 Million
83,791 Added 2.15%
3,985,650 $420 Million
Q2 2021

Aug 11, 2021

BUY
$125.11 - $180.0 $488 Million - $702 Million
3,901,859 New
3,901,859 $691 Million

Others Institutions Holding ZLAB

About Zai Lab Ltd


  • Ticker ZLAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,908,704
  • Market Cap $2.06B
  • Description
  • Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...
More about ZLAB
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.